ANTISEL at the 10th Scientific Symposium: HPV & Biomarkers in Obstetrics & Gynecology
Obstetrics and Gynecology
Effective prevention and targeted therapeutic management in women’s healthcare rely heavily on early detection, reliable screening biomarkers, and advanced surgical precision. From evaluating cervical pre-cancerous lesions and navigating population-based HPV screening to performing tissue-sparing minimally invasive procedures, modern gynecologists require integrated diagnostic and endoscopic platforms that optimize patient safety and clinical workflows.
HPV & Biomarkers in Obstetrics and Gynecology
Supporting the clinical pathway from diagnosis to intervention, ANTISEL’s advanced minimally invasive portfolio includes modern visualization and surgical technologies, such as the Mindray HyPixel UX7 Series, an all-in-one 4K, 3D, and Near-Infrared (NIR) fluorescence laparoscopic imaging platform, and Delmont Imaging’s innovative solutions designed for outpatient and operating room precision.
Join ANTISEL’s medical specialists at the 10th Scientific Symposium: HPV & Biomarkers in Obstetrics and Gynecology in Larissa to explore how we can empower practitioners to:
-
Achieve visualization in complex gynecological laparoscopy.
-
Perform atraumatic diagnostic and operative hysteroscopic examinations, elevating patient comfort and in-office procedural efficiency.
-
Bridge biomarker-guided diagnostics with minimally invasive surgical techniques to improve long-term outcomes for women.
